Each year Enlyte releases its drug trends series to analyze the state of pharmacy trends in workers’ comp. In part one of our 2025 series, we’re evaluating retail and mail order prescriptions.
Migraine medications are making up a growing portion of pharmacy spend in workers’ comp, driven by an influx of new CGRP antagonist medications to the market over the last few years.
The most recent annual review of drug utilization data from Optum revealed key trends that could shape workers’ comp care and policy developments in 2025 and beyond.
Expanding presumptions in workers’ comp are making it easier for workers to qualify for benefits related to mental injury, including PTSD, as well as certain cancers and other conditions.
Discover how to overcome key return-to-work challenges—like mental health, social factors, and delays—using data-driven strategies that accelerate recovery and improve outcomes in workers’ compensation.
A telephonic case manager used behavioral coaching and personalized support to guide an injured worker through recovery, overcoming psychological barriers and driving successful return-to-work outcome.